Concepedia

Scott A. Scarneo

SA

Statistics

Publications

9

Citations

194

H-Index

9

Active since

2018

Affiliations

Duke University(Current)

Bolder Biotechnology, Inc.

University of North Carolina at Chapel Hill

University of Michigan

Scott A. Scarneo is an author at Duke University specializing in inflammation, pathology, and oxidative stress.

ORCID

Top concepts

Publications per year

2018–2023

9

Publications

9

Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice

Scott A. Scarneo, Liesl S. Eibschutz, Phillip J. Bendele et al. · Arthritis Research & Therapy · 2019 · 49 citations · Full text

Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion

Scott A. Scarneo, Antoine Mansourati, Liesl S. Eibschutz et al. · Scientific Reports · 2018 · 32 citations · Full text

A highly selective inhibitor of interleukin-1 receptor–associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase

Scott A. Scarneo, Philip F. Hughes, Kelly W. Yang et al. · Journal of Biological Chemistry · 2019 · 26 citations · Full text

Development and Efficacy of an Orally Bioavailable Selective TAK1 Inhibitor for the Treatment of Inflammatory Arthritis

Scott A. Scarneo, Philip F. Hughes, Robert Freeze et al. · ACS Chemical Biology · 2022 · 23 citations · Full text

Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis

Swarna Bale, Priyanka Verma, Bharath Yalavarthi et al. · JCI Insight · 2023 · 20 citations · Full text

, , +22

1–5 of 9